13FPulse
中
ER

ERAS ERASCA INC

2026Q2 · CUSIP 29479A108 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
255
Institutions that reported holding it to the SEC
Net increase in holders
+31
Last quarter 224 → now 255
How unusual is that
Top 20%
Stronger buying than 90% of US stocks
What the filings say, in one paragraph

255 funds held ERAS at the end of 2026Q2, up 31 from the quarter before. That is stronger buying than 89.9% of US stocks — among the most piled-into names this quarter. On the business itself, return on equity is -79.4%. ERAS has had 6 buying rushes in its history, and the price moved -23.1% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2021Q4: holders=63 2022Q1: holders=82 2022Q2: holders=89 2022Q3: holders=88 2022Q4: holders=107 2023Q1: holders=118 2023Q2: holders=112 2023Q3: holders=108 2023Q4: holders=119 2024Q1: holders=109 2024Q2: holders=126 2024Q3: holders=132 2024Q4: holders=146 2025Q1: holders=154 2025Q2: holders=142 2025Q3: holders=143 2025Q4: holders=154 2026Q1: holders=224 2026Q2: holders=255 -70 -35 +0 +35 +70 56162268 21Q422Q222Q423Q223Q424Q224Q425Q225Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 6 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20% — —
2026Q1 Top 5% — —
2024Q2 Top 20% +0.4% -46.1%
2023Q1 Top 20% -12.8% -19.4%
2022Q2 Top 20% -15.2% -61.4%
2022Q1 Top 10% +61.6% +34.6%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
136
Change in large funds
+20
Total value they hold
$5.1B
Funds buying for the first time
64
Funds that sold out entirely
33
Price change that quarter
+75.6%
Funds holding puts (bearish)
6
Funds holding calls (bullish)
9

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.95
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-79.4%
Debt ratio
16.8%
FCF (TTM)
-$98M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.46 2022-03-31: EPS -0.31 2022-06-30: EPS -0.30 2022-09-30: EPS -0.29 2022-12-31: EPS -1.09 2023-03-31: EPS -0.22 2023-06-30: EPS -0.21 2023-09-30: EPS -0.20 2023-12-31: EPS -0.20 2024-03-31: EPS -0.23 2024-06-30: EPS -0.29 2024-09-30: EPS -0.11 2024-12-31: EPS -0.06 2025-03-31: EPS -0.11 2025-06-30: EPS -0.12 2025-09-30: EPS -0.11 2025-12-31: EPS -0.10 2026-03-31: EPS -0.60 2026-06-30: EPS -0.14 -1.20 -0.60 0.00 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-33M-17M0K 2020202120222023202420252026
Latest quarter $-27M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.